Hayata Tadayoshi, Ezura Yoichi, Asashima Makoto, Nishinakamura Ryuichi, Noda Masaki
Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
J Bone Miner Res. 2015 Feb;30(2):318-29. doi: 10.1002/jbmr.2343.
Transforming growth factor (TGF)-β signaling plays critical roles during skeletal development and its excessive signaling causes genetic diseases of connective tissues including Marfan syndrome and acromelic dysplasia. However, the mechanisms underlying prevention of excessive TGF-β signaling in skeletogenesis remain unclear. We previously reported that Dullard/Ctdnep1 encoding a small phosphatase is required for nephron maintenance after birth through suppression of bone morphogenetic protein (BMP) signaling. Unexpectedly, we found that Dullard is involved in suppression of TGF-β signaling during endochondral ossification. Conditional Dullard-deficient mice in the limb and sternum mesenchyme by Prx1-Cre displayed the impaired growth and ossification of skeletal elements leading to postnatal lethality. Dullard was expressed in early cartilage condensations and later in growth plate chondrocytes. The tibia growth plate of newborn Dullard mutant mice showed reduction of the proliferative and hypertrophic chondrocyte layers. The sternum showed deformity of cartilage primordia and delayed hypertrophy. Micromass culture experiments revealed that Dullard deficiency enhanced early cartilage condensation and differentiation, but suppressed mineralized hypertrophic chondrocyte differentiation, which was reversed by treatment with TGF-β type I receptor kinase blocker LY-364947. Dullard deficiency induced upregulation of protein levels of both phospho-Smad2/3 and total Smad2/3 in micromass cultures without increase of Smad2/3 mRNA levels, suggesting that Dullard may affect Smad2/3 protein stability. The phospho-Smad2/3 level was also upregulated in perichondrium and hypertrophic chondrocytes in Dullard-deficient embryos. Response to TGF-β signaling was enhanced in Dullard-deficient primary chondrocyte cultures at late, but not early, time point. Moreover, perinatal administration of LY-364947 ameliorated the sternum deformity in vivo. Thus, we identified Dullard as a new negative regulator of TGF-β signaling in endochondral ossification.
转化生长因子(TGF)-β信号通路在骨骼发育过程中发挥着关键作用,其过度信号传导会导致包括马凡综合征和肢端发育异常在内的结缔组织遗传性疾病。然而,在骨骼生成过程中预防TGF-β信号过度传导的潜在机制仍不清楚。我们之前报道过,编码一种小磷酸酶的Dullard/Ctdnep1通过抑制骨形态发生蛋白(BMP)信号通路,在出生后对肾单位维持是必需的。出乎意料的是,我们发现Dullard在软骨内骨化过程中参与抑制TGF-β信号通路。通过Prx1-Cre在肢体和胸骨间充质中条件性敲除Dullard的小鼠表现出骨骼元件生长和骨化受损,导致出生后死亡。Dullard在早期软骨凝聚物中表达,随后在生长板软骨细胞中表达。新生Dullard突变小鼠的胫骨生长板显示增殖和肥大软骨细胞层减少。胸骨显示软骨原基畸形和肥大延迟。微团培养实验表明,Dullard缺陷增强了早期软骨凝聚和分化,但抑制了矿化肥大软骨细胞分化,用TGF-β I型受体激酶阻滞剂LY-364947处理可逆转这种情况。Dullard缺陷在微团培养中诱导磷酸化Smad2/3和总Smad2/3蛋白水平上调,而Smad2/3 mRNA水平未增加,这表明Dullard可能影响Smad2/3蛋白稳定性。在Dullard缺陷胚胎的软骨膜和肥大软骨细胞中,磷酸化Smad2/3水平也上调。在晚期而非早期时间点,Dullard缺陷的原代软骨细胞培养物中对TGF-β信号的反应增强。此外,围产期给予LY-364947可改善体内胸骨畸形。因此,我们确定Dullard是软骨内骨化过程中TGF-β信号通路的一种新的负调节因子。